[PubMed] [PMC] Rotondo E, Chiarelli F (2020) Endocrine-disrupting chemicals and insulin resistance in children
Jing H, Tian G, Huinan Z, Xing W
TB-500 mobilizes the repair cells
Beyond the brain, these medications perform a vital dual role in your metabolic system
Certain thyroid conditions and predispositions require careful evaluation before initiating semaglutide or tirzepatide therapy
Costanza Alciati, a pharma analyst at GlobalData, told BioSpace in an email that GLP-1s will definitely dominate the market in the near future, but new entrants into the space are already looking for the next drug class that could revolutionize the space. Companies taking an alternative approach are forecast to capture only a very small portion of the obesity marketroughly 6.3%across the seven major markets (U.S., France, Germany, Italy, Spain, UK and Japan) by the end of 2031, according to Sara Reci, a senior analyst at GlobalData